Home Applications 212923 Application 212923
Type ANDA
Sponsor AUROBINDO PHARMA Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CLOZAPINE CLOZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 12.5MG No No 002 CLOZAPINE CLOZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 25MG No No 003 CLOZAPINE CLOZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 100MG No No 004 CLOZAPINE CLOZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 150MG No No 005 CLOZAPINE CLOZAPINE TABLET, ORALLY DISINTEGRATING;ORAL 200MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A212923-001 CLOZAPINE CLOZAPINE 12.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 A212923-002 CLOZAPINE CLOZAPINE 25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 A212923-003 CLOZAPINE CLOZAPINE 100MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 A212923-004 CLOZAPINE CLOZAPINE 150MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 A212923-005 CLOZAPINE CLOZAPINE 200MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 50 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212923-001 CLOZAPINE 12.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212923-002 CLOZAPINE 25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212923-003 CLOZAPINE 100MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212923-004 CLOZAPINE 150MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212923-005 CLOZAPINE 200MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 03ed91905a0d…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A212923-001 CLOZAPINE 12.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A212923-002 CLOZAPINE 25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A212923-003 CLOZAPINE 100MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A212923-004 CLOZAPINE 150MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A212923-005 CLOZAPINE 200MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2024-12-12 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 50 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Clozapine CLOZAPINE Aurobindo Pharma Limited caf2d4a6-2a23-4992-a807-560c4204afc4 2025-06-05 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 212923 application number: ANDA212923
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.